Academic Journals Database
Disseminating quality controlled scientific knowledge

ICH Q11: development and manufacture of drug substances–chemical and biotechnological/biological entities

ADD TO MY LIST
 
Author(s): Keith McDonald, MSc, MRPharmS | Kowid Ho, PhD

Journal: Generics and Biosimilars Initiative Journal
ISSN 2033-6403

Volume: 1;
Issue: 3-4;
Start page: 142;
Date: 2012;
Original page

Keywords: biotechnological and chemical substances | drug substance quality | ICH Q11

ABSTRACT
The International Conference on Harmonisation (ICH) has endorsed a new guideline concerning the development and manufacture of chemical and biotechnological/biological drug substances. The guideline harmonises the scientific and technical principles relating to the development and description of the drug substance manufacturing process to be included within the Common Technical Document (CTD) and submitted to regulatory authorities in the European Union (EU), Japan and USA. This question and answer is intended to provide the reader with a flavour of the background to the guideline and its relevance for biosimilar and generic drug substances.
Save time & money - Smart Internet Solutions     

Tango Jona
Tangokurs Rapperswil-Jona